These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 35006874)

  • 1. Molecular Tuning of the Nano-Bio Interface: Alpha-Synuclein's Surface Targeting with Doped Carbon Nanostructures.
    Alimohammadi E; Nikzad A; Khedri M; Shafiee S; Miri Jahromi A; Maleki R; Rezaei N
    ACS Appl Bio Mater; 2021 Aug; 4(8):6073-6083. PubMed ID: 35006874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Graphene-Based Nanoparticles as Potential Treatment Options for Parkinson's Disease: A Molecular Dynamics Study.
    Alimohammadi E; Khedri M; Miri Jahromi A; Maleki R; Rezaian M
    Int J Nanomedicine; 2020; 15():6887-6903. PubMed ID: 32982240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential treatment of Parkinson's disease using new-generation carbon nanotubes: a biomolecular
    Alimohammadi E; Nikzad A; Khedri M; Rezaian M; Jahromi AM; Rezaei N; Maleki R
    Nanomedicine (Lond); 2021 Feb; 16(3):189-204. PubMed ID: 33502255
    [No Abstract]   [Full Text] [Related]  

  • 4. Graphene oxide sheets and quantum dots inhibit α-synuclein amyloid formation by different mechanisms.
    Ghaeidamini M; Bernson D; Sasanian N; Kumar R; Esbjörner EK
    Nanoscale; 2020 Oct; 12(37):19450-19460. PubMed ID: 32959853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From two-dimension to one-dimension: the curvature effect of silicon-doped graphene and carbon nanotubes for oxygen reduction reaction.
    Zhang P; Hou X; Mi J; He Y; Lin L; Jiang Q; Dong M
    Phys Chem Chem Phys; 2014 Sep; 16(33):17479-86. PubMed ID: 25020255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineered graphene quantum dot nanocomposite triggers α-synuclein defibrillation: Therapeutics against Parkinson's disease.
    Kaliyaperumal P; Renganathan S; Arumugam K; Aremu BR
    Nanomedicine; 2023 Jan; 47():102608. PubMed ID: 36228996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Trehalose on Thermodynamic Properties of Alpha-synuclein Revealed through Synchrotron Radiation Circular Dichroism.
    Ruzza P; Hussain R; Biondi B; Calderan A; Tessari I; Bubacco L; Siligardi G
    Biomolecules; 2015 May; 5(2):724-34. PubMed ID: 25946077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic Understanding of the Interactions between Nano-Objects with Different Surface Properties and α-Synuclein.
    Mohammad-Beigi H; Hosseini A; Adeli M; Ejtehadi MR; Christiansen G; Sahin C; Tu Z; Tavakol M; Dilmaghani-Marand A; Nabipour I; Farzadfar F; Otzen DE; Mahmoudi M; Hajipour MJ
    ACS Nano; 2019 Mar; 13(3):3243-3256. PubMed ID: 30810027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-Synuclein conformation affects its tyrosine-dependent oxidative aggregation.
    Ruf RA; Lutz EA; Zigoneanu IG; Pielak GJ
    Biochemistry; 2008 Dec; 47(51):13604-9. PubMed ID: 19049426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical properties of lipids strongly affect the kinetics of the membrane-induced aggregation of α-synuclein.
    Galvagnion C; Brown JW; Ouberai MM; Flagmeier P; Vendruscolo M; Buell AK; Sparr E; Dobson CM
    Proc Natl Acad Sci U S A; 2016 Jun; 113(26):7065-70. PubMed ID: 27298346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Coarse-Grained Molecular Dynamics Approach to the Study of the Intrinsically Disordered Protein α-Synuclein.
    Ramis R; Ortega-Castro J; Casasnovas R; Mariño L; Vilanova B; Adrover M; Frau J
    J Chem Inf Model; 2019 Apr; 59(4):1458-1471. PubMed ID: 30933517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membrane Remodeling and Stimulation of Aggregation Following α-Synuclein Adsorption to Phosphotidylserine Vesicles.
    Hoover BM; Shen Z; Gahan CG; Lynn DM; Van Lehn RC; Murphy RM
    J Phys Chem B; 2021 Feb; 125(6):1582-1594. PubMed ID: 33538595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. alpha-Synuclein fission yeast model: concentration-dependent aggregation without plasma membrane localization or toxicity.
    Brandis KA; Holmes IF; England SJ; Sharma N; Kukreja L; DebBurman SK
    J Mol Neurosci; 2006; 28(2):179-91. PubMed ID: 16679557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Movement of prion-like α-synuclein along the gut-brain axis in Parkinson's disease: A potential target of curcumin treatment.
    Chetty D; Abrahams S; van Coller R; Carr J; Kenyon C; Bardien S
    Eur J Neurosci; 2021 Jul; 54(2):4695-4711. PubMed ID: 34043864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DJ-1, a Parkinson's disease related protein, aggregates under denaturing conditions and co-aggregates with α-synuclein through hydrophobic interaction.
    Zhu M; H Patel S; Han S
    Biochim Biophys Acta Gen Subj; 2017 Jul; 1861(7):1759-1769. PubMed ID: 28330770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The food additive fast green FCF inhibits α-synuclein aggregation, disassembles mature fibrils and protects against amyloid-induced neurotoxicity.
    Wang F; Wang Y; Jiang L; Wang W; Sang J; Wang X; Lu F; Liu F
    Food Funct; 2021 Jun; 12(12):5465-5477. PubMed ID: 33997868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The investigation of interaction and chaperon-like activity of α-synuclein as a protein in pathophysiology of Parkinson's disease upon direct interaction with tectorigenin.
    Tu W; Zheng C; Zheng Y; Feng Z; Lin H; Jiang Y; Chen W; Chen Y; Lee Y; Su J; Zheng W
    Int J Biol Macromol; 2023 Sep; 249():125702. PubMed ID: 37414324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulating α-synuclein fibril formation using DNA tetrahedron nanostructures.
    Yoo WK; Ryu BH; Kim KR; Wang Y; Le LTHL; Lee JH; Kim KK; Toth G; Ahn DR; Doohun Kim T
    Biochim Biophys Acta Gen Subj; 2019 Jan; 1863(1):73-81. PubMed ID: 30278239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. α-Synuclein misfolding and aggregation: Implications in Parkinson's disease pathogenesis.
    Mehra S; Sahay S; Maji SK
    Biochim Biophys Acta Proteins Proteom; 2019 Oct; 1867(10):890-908. PubMed ID: 30853581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine-induced conformational changes in alpha-synuclein.
    Outeiro TF; Klucken J; Bercury K; Tetzlaff J; Putcha P; Oliveira LM; Quintas A; McLean PJ; Hyman BT
    PLoS One; 2009 Sep; 4(9):e6906. PubMed ID: 19730729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.